English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Identification of Biomarkers in Spinocerebellar Ataxia 3

Only registered users can translate articles
Log In/Sign up
The link is saved to the clipboard
StatusActive, not recruiting
Sponsors
University of Michigan
Collaborators
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)

Keywords

Abstract

The purpose of this study is to examine the differences in cerebral spinal fluid (CSF) and blood of patients with spinocerebellar ataxias and healthy volunteers. The goal of this project is to identify new biomarkers that are useful for characterizing spinocerebellar ataxias and identify targets for treatment or prevention of this condition.

Description

Participants will undergo a SARA exam, a lumbar puncture and a blood draw. A lumbar puncture is a procedure in which a small amount of the spinal fluid that surrounds the brain and spinal cord is removed by inserting a needle in the lower back. Participants will be asked not to eat or drink anything (water is acceptable) for at least 6 hours before the lumbar puncture visit. For this procedure, participants will be positioned lying on their side and curled up in a ball, or sitting up and bent forward, whichever is easier. Cushions will be used to enhance comfort. The lower back region will be cleaned and disinfected with an antiseptic iodine solution. The doctor will inject local anesthetic (lidocaine, 1%) into the skin of the lower back. This may produce a transient, mild burning sensation. A very small needle will be introduced into the skin and moved into fluid-filled space around the spinal nerves coming from the spinal cord. This may produce a pressure sensation. Approximately 2 tablespoons approximately 30 ml) of fluid will be collected. The needle will be removed and a band-aid applied over the needle insertion site. Participants will be asked to remain stationary, lying on flat for about ½ hour on a bed in the research clinic. Participants will be given something to eat and drink before leaving. Strenuous physical activity should be avoided for the next 24 hours. This includes lifting, bending, doing housework and gardening, or doing exercise such as jogging or bicycle riding. The SARA (Scale for the Assessment and Rating of Ataxia) exam is a clinical scale that assesses a range of different impairments in cerebellar ataxia. The scale is made up of 8 items related to gait, stance, sitting, speech, fingerchase test, nose-finger test, fast alternating movements and heel-shin test, and takes approximately 15 minutes to complete.

The study also involves a single collection of about 3.5 tablespoons (approximately 50 ml) of blood. This blood draw may take place during a regularly scheduled visit to the neurology clinic or at the research appointment.

Dates

Last Verified: 03/31/2020
First Submitted: 03/18/2019
Estimated Enrollment Submitted: 03/18/2019
First Posted: 03/20/2019
Last Update Submitted: 04/01/2020
Last Update Posted: 04/05/2020
Actual Study Start Date: 02/20/2019
Estimated Primary Completion Date: 11/30/2021
Estimated Study Completion Date: 11/30/2021

Condition or disease

Spinocerebellar Ataxia Type 3

Intervention/treatment

Other: Specimen Collection

Phase

-

Arm Groups

ArmIntervention/treatment
Affected Individuals with Known SCA3
In order to be eligible for this cohort, participants must have confirmed genetic testing results for Spinocerebellar Ataxia Type 3.
Healthy Individual Control Subjects
In order to be eligible for this cohort, subjects must not have a diagnosis of Spinocerebellar Ataxia Type 3 and no major medical issues including but not limited to conditions that would cause an unsafe specimen collection.

Eligibility Criteria

Ages Eligible for Study 18 Years To 18 Years
Sexes Eligible for StudyAll
Sampling methodNon-Probability Sample
Accepts Healthy VolunteersYes
Criteria

Inclusion Criteria:

•Confirmed Genetic Testing of SCA3 or Healthy Volunteers

Exclusion Criteria:

- People with:

- unstable thyroid

- unstable intestinal/stomach issues

- unstable heart issues

- unstable liver issues

- unstable kidney issues

- unstable lung issues

- unstable hormone issues

- unstable mental disorders at screening

- a tumor or evidence of having a tumor

- a chronic infection or any severe acute infection within 3 months prior to screening

- People who:

- Take anti-coagulants and NSAIDs

- Have started any investigational medications in the last month

- Women who are pregnant or breast feeding

Outcome

Primary Outcome Measures

1. Change in Ataxin 3 Levels in Cerebrospinal Fluid Specimens [4 Hours]

A lumbar puncture is performed to collect CSF.

2. Change in Ataxin 3 Levels in Blood Plasma Specimens [4 Hours]

A single blood draw is completed.

Join our facebook page

The most complete medicinal herbs database backed by science

  • Works in 55 languages
  • Herbal cures backed by science
  • Herbs recognition by image
  • Interactive GPS map - tag herbs on location (coming soon)
  • Read scientific publications related to your search
  • Search medicinal herbs by their effects
  • Organize your interests and stay up do date with the news research, clinical trials and patents

Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research

Google Play badgeApp Store badge